Skip to main content
. 2017 Jan 14;8(12):19534–19546. doi: 10.18632/oncotarget.14663

Figure 8. ZFAS1 promotes EOC cells through miR-150-5p mediated Sp1.

Figure 8

A, B. Relative mRNA and protein expression in five group of Caov3 and SKOV3 cells (no transfection, siR-Control + anti-miR-Control, siR-ZFAS1 + anti-miR-Control, siR-Control + anti-miR-150-5p and siR-ZFAS1 + anti-miR-150-5p) determined by qRT-PCR and western blot. C, D, E. MTT cell proliferation, migration and invasion assays in five group of Caov3 and SKOV3 cells (no transfection, siR-Control + anti-miR-Control, siR-ZFAS1 + anti-miR-Control, siR-Control + anti-miR-150-5p and siR-ZFAS1 + anti-miR-150-5p). F, G. Colony formation assays in Caov3 and SKOV3 cells treated with Cisplatin (8 μM) or Paclitaxel (50 nM).*p<0.05 and**p<0.01 compared to no transfection cells.